Cargando…
Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance
Most cancers are resistant to anti-PD-1/PD-L1 and chemotherapy. Herein we identify PDLIM2 as a tumor suppressor particularly important for lung cancer therapeutic responses. While PDLIM2 is epigenetically repressed in human lung cancer, associating with therapeutic resistance and poor prognosis, its...
Autores principales: | Sun, Fan, Li, Liwen, Yan, Pengrong, Zhou, Jingjiao, Shapiro, Steven D., Xiao, Gutian, Qu, Zhaoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876573/ https://www.ncbi.nlm.nih.gov/pubmed/31757943 http://dx.doi.org/10.1038/s41467-019-13331-x |
Ejemplares similares
-
PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis
por: Li, Liwen, et al.
Publicado: (2021) -
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease
por: Qu, Zhaoxia, et al.
Publicado: (2012) -
Differential roles of STAT3 in the initiation and growth of lung cancer
por: Zhou, Jingjiao, et al.
Publicado: (2014) -
An Overview of the Cytoskeleton-Associated Role of PDLIM5
por: Huang, Xiaolan, et al.
Publicado: (2020) -
NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function
por: Sun, Fan, et al.
Publicado: (2015)